These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7619355)

  • 1. Changes of vascular architecture independent of blood pressure in experimental uremia.
    Amann K; Neusüss R; Ritz E; Irzyniec T; Wiest G; Mall G
    Am J Hypertens; 1995 Apr; 8(4 Pt 1):409-17. PubMed ID: 7619355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood-pressure-independent wall thickening of intramyocardial arterioles in experimental uraemia: evidence for a permissive action of PTH.
    Amann K; Törnig J; Flechtenmacher C; Nabokov A; Mall G; Ritz E
    Nephrol Dial Transplant; 1995 Nov; 10(11):2043-8. PubMed ID: 8643165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural remodeling of resistance arteries in uremic hypertension.
    New DI; Chesser AM; Thuraisingham RC; Yaqoob MM
    Kidney Int; 2004 May; 65(5):1818-25. PubMed ID: 15086922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ACE inhibition and bradykinin antagonism on cardiovascular changes in uremic rats.
    Amann K; Gassmann P; Buzello M; Orth SR; Törnig J; Gross ML; Magener A; Mall G; Ritz E
    Kidney Int; 2000 Jul; 58(1):153-61. PubMed ID: 10886560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced capillary density in the myocardium of uremic rats--a stereological study.
    Amann K; Wiest G; Zimmer G; Gretz N; Ritz E; Mall G
    Kidney Int; 1992 Nov; 42(5):1079-85. PubMed ID: 1453595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin receptor antagonists influence cardiovascular morphology in uremic rats.
    Nabokov AV; Amann K; Wessels S; Münter K; Wagner J; Ritz E
    Kidney Int; 1999 Feb; 55(2):512-9. PubMed ID: 9987075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aortic changes in experimental renal failure: hyperplasia or hypertrophy of smooth muscle cells?
    Amann K; Wolf B; Nichols C; Törnig J; Schwarz U; Zeier M; Mall G; Ritz E
    Hypertension; 1997 Mar; 29(3):770-5. PubMed ID: 9052894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of antioxidant therapy with dl-alpha-tocopherol on cardiovascular structure in experimental renal failure.
    Amann K; Törnig J; Buzello M; Kuhlmann A; Gross ML; Adamczak M; Buzello M; Ritz E
    Kidney Int; 2002 Sep; 62(3):877-84. PubMed ID: 12164869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble guanylate cyclase stimulator BAY 41-8543 and female sex ameliorate uremic aortic remodeling in a rat model of mild uremia.
    Stancu B; Krämer S; Loof T; Mika A; Amann K; Neumayer HH; Peters H
    J Hypertens; 2015 Sep; 33(9):1907-20; discussion 1921. PubMed ID: 26176653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased infarct size in uremic rats: reduced ischemia tolerance?
    Dikow R; Kihm LP; Zeier M; Kapitza J; Törnig J; Amann K; Tiefenbacher C; Ritz E
    J Am Soc Nephrol; 2004 Jun; 15(6):1530-6. PubMed ID: 15153563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of anemia and uremia and a combination of both on cardiovascular structures.
    Jürgensen JS; Grimm R; Benz K; Philipp S; Eckardt KU; Amann K
    Kidney Blood Press Res; 2010; 33(4):274-81. PubMed ID: 20628260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertrophy of intramyocardial arteriolar smooth muscle cells in experimental renal failure.
    Törnig J; Gross ML; Simonaviciene A; Mall G; Ritz E; Amann K
    J Am Soc Nephrol; 1999 Jan; 10(1):77-83. PubMed ID: 9890312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia.
    Amann K; Törnig J; Kugel B; Gross ML; Tyralla K; El-Shakmak A; Szabo A; Ritz E
    Kidney Int; 2003 Apr; 63(4):1296-301. PubMed ID: 12631346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced expression of the endothelin-1 gene in blood vessels of DOCA-salt hypertensive rats: correlation with vascular structure.
    Schiffrin EL; Larivière R; Li JS; Sventek P
    J Vasc Res; 1996; 33(3):235-48. PubMed ID: 8924521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of ramipril, nifedipine, and moxonidine on glomerular morphology and podocyte structure in experimental renal failure.
    Amann K; Nichols C; Tornig J; Schwarz U; Zeier M; Mall G; Ritz E
    Nephrol Dial Transplant; 1996 Jun; 11(6):1003-11. PubMed ID: 8671960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibition reduces diabetes-induced vascular hypertrophy: morphometric studies.
    Vranes D; Cooper ME; Dilley RJ
    J Vasc Res; 1995; 32(3):183-9. PubMed ID: 7772678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia.
    Cozzolino M; Staniforth ME; Liapis H; Finch J; Burke SK; Dusso AS; Slatopolsky E
    Kidney Int; 2003 Nov; 64(5):1653-61. PubMed ID: 14531797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M; Rodrigue ME; Agharazii M; Larivière R
    Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of long-acting calcium entry blocker (anipamil) on blood pressure, renal function and survival of uremic rats.
    Jarusiripipat C; Chan L; Shapiro JI; Schrier RW
    J Pharmacol Exp Ther; 1992 Jan; 260(1):243-7. PubMed ID: 1731040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased immunoreactive endothelin-1 levels in blood vessels and glomeruli of rats with reduced renal mass.
    Larivière R; D'Amours M; Lebel M; Kingma I; Grose JH; Caron L
    Kidney Blood Press Res; 1997; 20(6):372-80. PubMed ID: 9453448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.